News | News By Subject | News by Disease News By Date | Search News
Get Our FREE
Industry eNewsletter
email:    
   

AstraZeneca PLC (AZN) Chases Demon Disease Cure, Potential To Be A Blockbuster Drug



2/14/2014 7:15:55 AM

free biotech news Get the latest biotech news where you want it. Sign up for the free GenePool newsletter today!

In 1785, the caricaturist Henry William Bunbury declared strong drink, aided by a demon, as the cause of the painful inflammatory disease known as gout. Two hundred years later, AstraZeneca Plc (AZN) may be on the verge of winning approval for a more effective treatment for the malady. Gout is having a resurgence, fueled by increasing rates of obesity and poor diet.

Help employers find you! Check out all the jobs and post your resume.

Read at Bloomberg


comments powered by Disqus
Bloomberg
   

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES